Contract Research Organizations (CROs) offer end-to-end solutions in conducting clinical trials for pharmaceutical, biotechnology and medical device companies, collectively referred to as sponsors.
The top 5 companies covered are IQVIA, PPD (Private), Syneos Health, PAREXEL and PRA Health Sciences.
IQVIA was the largest company in the market.
The countries covered are USA, Japan, Germany, France, Australia, Brazil, Italy, China, Russia, Spain, UK, India and others.
The global CRO market was valued at $44.4 billion in 2017.
North America was the largest region in the global CRO market accounting for less than 45% share of the market. The USA was the largest country in the global CRO market, with around 33% share of the market.
Major trends shaping the CRO market include increasing focus on emerging markets, real world evidence in clinical trials, strategic partnerships to benefit cros and sponsors alike, adaptive trial design, increase in M&A activity, growing investments in technology, and personalized medicine/genetic testing capabilities.
Opioids and Other Analgesics Are The Fastest-Growing Neurology Drugs
North America`s Cardiovascular Drugs Market To Shrink 5% 2013-21
Biologics Logistics Outsourcing Market Growth Nearly Twice Other Pharma`s
Challenges To Big Pharma Are Helping Drive The Bio-Pharmaceutical Logistics Market
Over 1000 Biologics Under Development Will Drive The Biologics Market To 10% Yearly Growth
Public Policy Restrains Blood Glucose Test Strips Market Growth
The Leading Players In The Cardiovascular Devices Market Are Innovating To Stay Ahead
India Is The World’s Fastest-Growing Market For In-Vitro Diagnostics
Blood Glucose Test Strips Global Market Report 2018
Veterinary Services Global Market Report 2018
Podiatry Services Global Market Strategies and Opportunities to 2021
Nephrology And Urology Devices Market Global Briefing 2018
Neurology Devices Market Global Briefing 2018
ENT Devices Market Global Briefing 2018
Orthopedic Devices Market Global Briefing 2018
Wound Care Devices Market Global Briefing 2018